Coronavirus LIVE updates: Over 3.43 million Covid cases in India so far

Coronavirus LIVE updates: Over 3.43 million Covid cases in India so far, 4.61 lakh deaths.

New Delhi: India on Tuesday saw the lowest daily increase in coronavirus cases since early February with 10,126 new infections in a sign of relief as the country expects an increase in the rate of vaccination amid the fight against COVID-19.

The nation’s number of active cases is 1,40,638, which is the lowest in 263 days. The country has registered 3,43,66,987 cases since the start of the pandemic.

Meanwhile, India’s homegrown Covaxin, which got WHO approval last week, has been recognized by the UK. Quarantine is not required for fully vaccinated travelers in Britain as part of the new rules effective from 22 November.

Drugmakers Pfizer and BioNTech announced Tuesday that they formally submitted an application asking US officials for emergency authorization of their Covid-19 booster vaccine for people over 18 years of age.

The measure follows research published by the companies in late October that indicates a third injection is 95.6 percent effective against symptomatic infection, based on clinical trials conducted on 10,000 people.

The companies asked the US Food and Drug Administration to add the new population segment, modifying the emergency use authorization already granted in September for the third dose for all people 65 years of age and older, as well as for people at high risk of developing severe Covid-19.

Waiting for the “second generation” of Covid vaccines: WHO chief scientist

The World Health Organization chief scientist said Tuesday that she was looking forward to the “second generation” of Covid-19 vaccines, which could include nasal sprays and oral versions.

Soumya Swaminathan said that these vaccines could have advantages over the current crop, as they would be easier to administer than injections and could even be self-administered.

Swaminathan said there were 129 different candidate vaccines that have gone as far as clinical trials, which are being tested in humans, while another 194 are not yet that advanced in development and are still in the works in laboratories.

“This covers the whole range of technologies,” he said in a live interaction on the WHO’s social media channels.

“They are still in development. I’m sure some of them will prove to be very safe and effective and some will not.